COMMUNIQUÉS West-GlobeNewswire

Treos Bio Announces Positive Interim Results from a Phase 1/2 Clinical Trial of Precision Cancer Vaccine Plus Maintenance Therapy in Patients with Metastatic Colorectal Cancer
28/05/2019
Study will be presented in poster session at the 2019 ASCO Annual Meeting LONDON, May 28, 2019 (GLOBE NEWSWIRE) -- Treos Bio Limited, an immuno-oncology company developing next-generation, precision cancer vaccines [...]
Corcept Therapeutics to Present Data from Phase 1/2 Trial of Relacorilant Plus Nab-Paclitaxel in Patients with Solid Tumors at the American Society of Clinical Oncology Annual Meeting
28/05/2019
MENLO PARK, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs that treat severe metabolic, oncologic [...]
Avid Bioservices to Participate at BIO International Convention 2019
28/05/2019
-- Company to Provide Insight on Key CDMO Industry Topics through Podium Presentation, Panel Discussion and Executive Interview as Part of Convention’s BioProcess International Theater -- -- Corporate Booth to Highlight [...]
Tyme Technologies to Present at the Jefferies 2019 Global Healthcare Conference on June 7, 2019
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the [...]
Matinas BioPharma Announces Publication of MAT2203 Preclinical Cryptococcal Meningitis Data in the American Society for Microbiology Journal, mBio
28/05/2019
– Efficacy of oral delivery of amphotericin B (MAT2203) demonstrated comparable efficacy to IV amphotericin, with similar survival of animals and reduction in fungal burden – – Cryptococcal meningitis is one of the most [...]
Spring Bank Pharmaceuticals to Present at Jefferies 2019 Global Healthcare Conference
28/05/2019
HOPKINTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
Catalyst Biosciences to Present at the Jefferies 2019 Global Healthcare Conference
28/05/2019
SOUTH SAN FRANCISCO, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced that Nassim Usman, Ph.D., president and chief executive officer of Catalyst Biosciences, will [...]
Progressive Care Inc. Announces Closing Date for Acquisition of Florida Pharmacies
28/05/2019
MIAMI, May 28, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, announced today the closing date of June 1, 2019 for the acquisition of Family [...]
CytomX Therapeutics to Present at Upcoming Healthcare Conferences
28/05/2019
SOUTH SAN FRANCISCO, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
IntelGenx Receives First Shipment of Cannabis Extract from Tilray® for Production of Cannabis-Infused Oral Film
28/05/2019
SAINT LAURENT, Quebec, May 28, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today provided an update on its cannabis-infused VersaFilm ® product [...]
Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer
28/05/2019
CAMBRIDGE, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc., (NASDAQ:NTLA) has named Laura Sepp-Lorenzino, Ph.D., as its new executive vice president and chief scientific officer. Dr. Sepp-Lorenzino [...]
VIVUS Initiates Phase Four Safety and Efficacy Study of Qsymia® in Obese Adolescents
28/05/2019
-Post-marketing study designed to evaluate Qsymia as an approach to weight management in a growing patient population with significant unmet medical need- CAMPBELL, Calif., May 28, 2019 (GLOBE NEWSWIRE) -- VIVUS, Inc. ( [...]
Translate Bio to Present at the Jefferies 2019 Healthcare Conference
28/05/2019
LEXINGTON, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- Translate Bio, Inc. (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines to treat [...]
Onconova Therapeutics Announces Presentations at Three Upcoming Conferences
28/05/2019
NEWTOWN, Pa., May 28, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial [...]
Applied Therapeutics Announces FDA Orphan Drug Designation for AT-007 in Galactosemia
28/05/2019
NEW YORK, May 28, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in [...]
ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer’s Disease with Selectivity for the Neurotoxic Form of Tau
28/05/2019
Pipeline offers critical “one-two punch” in potential treatment arsenal for Alzheimer’s disease TORONTO and CAMBRIDGE, Mass., May 28, 2019 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a [...]
Akcea Therapeutics to Present at Upcoming Investor Conferences
28/05/2019
BOSTON, May 28, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious and rare [...]
Kezar Life Sciences Announces Acceptance of Abstract for Presentation of First in Patient Study with KZR-616 at EULAR 2019 Annual Meeting
28/05/2019
Abstract highlights preliminary results from the first two cohorts of the Phase 1b portion of the MISSION Trial in patients with systemic lupus erythematosus (SLE) Detailed poster with additional results will be [...]
RedHill Biopharma Appoints Dr. June Almenoff as Chief Scientific Officer
28/05/2019
TEL-AVIV, Israel and RALEIGH, N.C., May 28, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq: RDHL ) (Tel-Aviv Stock Exchange: RDHL ) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]

Pages